These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25139714)

  • 41. The expression of B7-H3 and B7-H4 in human gallbladder carcinoma and their clinical implications.
    Liu CL; Zang XX; Huang H; Zhang H; Wang C; Kong YL; Zhang HY
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4466-4473. PubMed ID: 27874953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
    Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
    FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
    Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
    [No Abstract]   [Full Text] [Related]  

  • 45. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
    Kim NI; Park MH; Kweon SS; Lee JS
    Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.
    Loos M; Hedderich DM; Ottenhausen M; Giese NA; Laschinger M; Esposito I; Kleeff J; Friess H
    BMC Cancer; 2009 Dec; 9():463. PubMed ID: 20035626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
    Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
    Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The type 1 transmembrane glycoprotein B7-H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells.
    Zuo J; Wang B; Long M; Gao Z; Zhang Z; Wang H; Wang X; Li R; Dong K; Zhang H
    FEBS Lett; 2018 Jul; 592(14):2476-2488. PubMed ID: 29924389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent B7-H3 overexpression in craniopharyngioma.
    Chen C; Wang Y; Zhong K; Jiang C; Wang L; Yuan Z; Nie C; Xu J; Guo G; Zhou L; Yang M; Tong A
    Biochem Biophys Res Commun; 2019 Jun; 514(2):379-385. PubMed ID: 31043272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B7-H3 protein expression in acute myeloid leukemia.
    Guery T; Roumier C; Berthon C; Renneville A; Preudhomme C; Quesnel B
    Cancer Med; 2015 Dec; 4(12):1879-83. PubMed ID: 26376842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer.
    Li ZY; Wang JT; Chen G; Shan ZG; Wang TT; Shen Y; Chen J; Yan ZB; Peng LS; Mao FY; Teng YS; Liu JS; Zhou YY; Zhao YL; Zhuang Y
    Clin Immunol; 2021 Jun; 227():108753. PubMed ID: 33945871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression status of PD-L1 and B7-H3 in mesothelioma.
    Matsumura E; Kajino K; Abe M; Ohtsuji N; Saeki H; Hlaing MT; Hino O
    Pathol Int; 2020 Dec; 70(12):999-1008. PubMed ID: 33027549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
    Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
    Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
    Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear oxidative damage correlates with poor survival in colorectal cancer.
    Sheridan J; Wang LM; Tosetto M; Sheahan K; Hyland J; Fennelly D; O'Donoghue D; Mulcahy H; O'Sullivan J
    Br J Cancer; 2009 Jan; 100(2):381-8. PubMed ID: 19066606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer.
    Zhang T; Jin Y; Jiang X; Li L; Qi X; Mao Y; Hua D
    Front Oncol; 2020; 10():546110. PubMed ID: 33042836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.